A Large-Scale Population Study of Its Associated Comorbidities

Manuel Almenara-Blasco,Tamara Gracia-Cazaña,Beatriz Poblador-Plou,Clara Laguna-Berna,Jonás Carmona-Pírez,Alba Navarro-Bielsa,Alexandra Prados-Torres,Antonio Gimeno-Miguel,Yolanda Gilaberte
DOI: https://doi.org/10.3390/jcm13020492
IF: 3.9
2024-01-17
Journal of Clinical Medicine
Abstract:Introduction: Psoriasis is a chronic disease of the skin with a prevalence of 2% in the general population. The high prevalence of psoriasis has prompted the study of its comorbidities in recent decades. We designed a study to determine the prevalence of psoriasis in a large-scale, population-based cohort, to exhaustively describe its comorbidities, and to analyze which diseases are associated with psoriasis. Methods: Retrospective, observational study based on the clinical information contained in the electronic health records of the individuals in the EpiChron Cohort with a diagnosis of psoriasis (31,178 individuals) in 2019. We used logistic regression models and calculated the likelihood of the occurrence of each comorbidity based on the presence of psoriasis (p-value < 0.05). Results: The prevalence of psoriasis was 2.84%, and it was more prevalent in men (3.31% vs. 2.43%). The most frequent chronic comorbidities were disorders of lipid metabolism (35.87%), hypertension (35.50%), and other nutritional-endocrine-metabolic disorders (21.79%). The conditions most associated with psoriasis were (odds ratio; 95% confidence interval) tuberculosis (2.36; 1.24–4.49), cystic fibrosis (2.15; 1.25–3.69), amongst others. We did not find a significant association between psoriasis and hypertension or neoplasms (0.90; 0.86–0.95). Conclusions: This study revealed significant associations between psoriasis and cardiac, psychological, and musculoskeletal comorbidities.
medicine, general & internal
What problem does this paper attempt to address?
### Problems the paper attempts to solve This paper aims to solve the following problems: 1. **Determine the prevalence of psoriasis in a large - scale population in the Aragon region of Spain**: Researchers hope to understand the actual prevalence of psoriasis in this region by analyzing a large amount of population data. 2. **Comprehensively describe the comorbidities of psoriasis patients**: Through detailed clinical data analysis, researchers hope to reveal the common chronic and acute diseases among psoriasis patients. 3. **Analyze which diseases are systematically associated with psoriasis**: Using statistical methods (such as logistic regression models), researchers attempt to find out which diseases have significantly increased or decreased risks in psoriasis patients. ### Research background Psoriasis is a chronic inflammatory skin disease with a complex pathogenesis, which is affected by genetic and environmental factors. The global prevalence of psoriasis is approximately 2%, but it varies in different regions. For example, in the United States and Canada, the prevalence is approximately 5%, while in Asia, the prevalence is between 0.4% and 0.7%. Psoriasis not only affects the skin but is also associated with a variety of other health problems, including cardiovascular diseases, metabolic syndrome, mental health problems, etc. However, the relationship between psoriasis and certain diseases (such as tumors and multiple sclerosis) is still unclear. ### Research methods The researchers adopted a retrospective observational study design based on the electronic health records (EHRs) and clinical administrative databases of the EpiChron cohort in the Aragon region. The study subjects included 31,178 patients diagnosed with psoriasis in 2019. The researchers used logistic regression models to calculate the probability of occurrence of each comorbidity in psoriasis patients and adjusted for the effects of gender and age. ### Main results 1. **Prevalence of psoriasis**: The overall prevalence was 2.84%, and the prevalence in men (3.31%) was higher than that in women (2.43%). 2. **Most common chronic comorbidities**: - Lipid metabolism disorders (35.87%) - Hypertension (35.50%) - Other nutritional - endocrine - metabolic disorders (21.79%) 3. **Diseases significantly associated with psoriasis** (adjusted odds ratio; 95% confidence interval): - Tuberculosis (2.36; 1.24 - 4.49) - Cystic fibrosis (2.15; 1.25 - 3.69) - Otitis externa (1.65; 1.44 - 1.88) 4. **Diseases with no significant association found**: - Hypertension (0.90; 0.86 - 0.95) - Tumors ### Conclusion This study reveals significant associations between psoriasis and cardiac, psychological, and musculoskeletal diseases. These findings are helpful for better understanding the comprehensive health status of psoriasis patients and providing a basis for formulating personalized treatment plans.